Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. - Wikidata - awgldk - TriplyDB

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

http://www.wikidata.org/entity/Q35718583

about

Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.Knowledge, patterns of care, and outcomes of care for generalists and specialists.Non ST-elevation acute coronary syndrome.The secondary prevention of myocardial infarction by drug treatment; excluding lipid lowering agents.Reducing the risk for coronary heart disease and stroke in hypertensives--comments on mechanisms for coronary protection and quality of life.Angiotensin converting enzyme inhibitors for hypertension and heart failure?SBC guidelines on unstable angina and non-ST-elevation myocardial infarction: executive summary.Pharmacotherapy of unstable angina.Management of patients with type 2 diabetes after acute coronary syndromes.Thrombin receptor and ventricular arrhythmias after acute myocardial infarction.Management of patients after their first myocardial infarction The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology 'hot topic'.Acute coronary syndrome (unstable angina and non-ST elevation MI).Role of antiischemic agents in the management of non-ST elevation acute coronary syndrome (NSTE-ACS).Options in antihypertensive drug therapy. Help in choosing from among the many agents.Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Calcium channel blockers and hypertension: 2. Safety issues.Slowly acting calcium antagonists and their merits.British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction.Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment Secondary prophylaxis against myocardial infarction.Are calcium antagonists safe in hypertension?Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters.Unstable angina pectoris.Calcium channel blockers in myocardial infarction: Authors' reply.Conundrum of the HOPE study: Authors' reply.Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina Pectoris.The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

P2860

Q24240551-BF3E802B-574B-46A3-91C9-B3F4C654CAF0 Q30583012-A949C9BC-CF4B-4F06-A6DB-95DE7E6C5548 Q33662185-325925C5-2EA5-472C-932B-2174C3812C13 Q33734633-90762302-D6C2-49FE-8822-0417491950FE Q33846765-346B5509-9AEE-42B4-BB80-C4A1D0AC5AB2 Q35251074-0B2026BE-8CDE-4EEF-836F-0475F8A3EB3B Q35917910-29DB2F8B-A634-4C19-BD90-EFAFFA61D360 Q35990307-D089B8DB-9FEE-4DF0-9E36-9F9B211A7E6A Q36116996-6F7E6C12-8D17-4ED1-A7A8-384C39B5D0C4 Q36119403-8809BB8B-B4E9-44E9-AD4D-4016B877B550 Q36333931-1F1C7463-5E03-4982-9F29-1CCE95644C36 Q36405459-F56F9828-0735-4E02-8ABF-0226266CFEB6 Q36888741-B5AA3516-09A4-4FEC-820B-AAAF64EB4761 Q37331867-57E72D19-42F1-42E9-84FD-5EDEA4103EA6 Q37484189-DB2C359B-D201-49F1-AEF1-7C381962D524 Q37788728-AAFBBF56-6157-4C74-879E-E3DB7F37C685 Q40926109-4DD3E65D-260F-484D-BD92-A6CBB14369EB Q41066089-485EB813-63A1-4BF3-B2C2-D84D124AFEE6 Q41272827-096A3F96-8745-4681-B82C-64A3EAA4DBA2 Q41432917-99631AFA-1B42-4850-A30A-70AE9F3E44F0 Q41972247-A96DA646-A9AD-4C4E-9024-152FC9A6DDE3 Q42332637-7AE615FD-EBFC-4098-BF61-696C9F6A31C0 Q43165592-061B9ADC-034A-40A8-AF36-1CD0368DBBDE Q43239433-89A209F6-165D-4706-8650-73A0C817A2F6 Q44035606-DF2EC41F-5018-4B97-8B01-F0B677C2C029 Q49967981-8C0787DA-60A3-4C8C-8DEE-4BF8681A9F4B Q50355507-4D3B22BF-AF05-4B78-B173-2C3A556C01ED Q50427692-507C75B8-5F68-4BB3-803A-543627C75CBE Q54062028-067AE154-4F3B-4079-9B25-E417D0EE5225 Q57583407-60C1CBBF-B039-4DF2-804D-95B72142D9C7

P2860

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

http://www.wikidata.org/entity/Q35718583

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

1989年论文

@zh

1989年论文

@zh-cn

name

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@ast

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@en

type

label

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@ast

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@en

prefLabel

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@ast

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@en

P1433

Q35718583-86B03134-1D2B-4780-BD02-6CA1EE5D0564

P1476

Q35718583-AA1BEB9B-E27F-4FEF-B493-DF62E0218973

P2093

Q35718583-3B0E3DDA-33F9-4AF0-9E1F-7EB9C09AE4CE

Q35718583-7748E713-9490-4A2F-9B4B-0A27B9FC3E3E

Q35718583-C76BA22D-4528-4F2D-9815-82F54F86631A

P2860

Q35718583-0622937C-E005-4E8A-BD64-D107028B8612

Q35718583-18166609-1A9C-4E77-8EB1-187EF2DA7D45

Q35718583-4DC3B561-0E43-4FFE-9E95-6E3836CB3BAE

Q35718583-50879E0E-B764-4E5E-88A6-71F0FB87B9F8

Q35718583-5971C9FD-2336-474E-BAA0-62322E175274

Q35718583-60A31C11-EAB8-4FF7-8274-127AEB60D197

Q35718583-6119A883-2A38-4F13-938D-7D8BDC2263F4

Q35718583-6EA8ACFA-173D-4395-A8EE-1FF0B62C5CC5

Q35718583-7B630236-7B3E-4725-B96E-873CDB33445F

Q35718583-9F64BCE9-7EBF-4BF3-9BF5-7CF913595315

P304

Q35718583-6C7BB0BE-3E95-4E44-9BED-C651374369C7

P31

Q35718583-D4B8EAFF-FFF1-4754-923E-368175769696

P356

Q35718583-302B7337-FDAC-496F-A817-127B7445FB13

P407

Q35718583-11713C35-2681-4918-8206-EBBCD804E810

P433

Q35718583-CDF90D26-E3C4-4ED8-9049-674E0DE44DE9

P478

Q35718583-752A7C80-6204-4667-A7C4-B3C109B37AA3

P577

Q35718583-F8BEEA6B-57C2-4326-B990-321E122F97D7

P5875

Q35718583-6D7F5B81-9867-41C5-A447-201A1FF81D10

P698

Q35718583-7843CA44-0CF8-4789-985B-625A7158BD9F

P921

Q35718583-14E41EBD-CC79-465F-B770-EF5CEA09F874

P932

Q35718583-93738281-FC9F-4E06-9BE6-F241EF271BD8

P356

BMJ.299.6709.1187

P1433

P1476

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

@en

P2093

Furberg CD

http://www.w3.org/2001/XMLSchema#string

Held PH

http://www.w3.org/2001/XMLSchema#string

Yusuf S

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.

Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial

Trial of early nifedipine in acute myocardial infarction: the Trent study

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.

Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.

Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.

Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest--a randomized trial in 70 patients.

Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit.

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

P304

1187-1192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.299.6709.1187

http://www.w3.org/2001/XMLSchema#string

P407

P433

6709

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P577

1989-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20643189

http://www.w3.org/2001/XMLSchema#string

P698

2513047

http://www.w3.org/2001/XMLSchema#string

P921

P932

1838102

http://www.w3.org/2001/XMLSchema#string